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Abstract
Background: Some studies have previously found that certain elevated early maladaptive schemas (EMSs) are
negative predictors for outcome for patients with obsessive-compulsive disorder (OCD) treated with Cognitive-
Behavioral Therapy (CBT) or Exposure and Response Prevention (ERP). The current study explores whether EMS were
related to reductions in OCD symptom severity at long-term follow-up (Mean = 8 years) after group ERP for patients
with OCD. The central hypothesis was that patients with no response to treatment or patients who relapsed during
the follow-up period were more likely to have elevated pre-treatment EMSs compared to those who responded to
initial treatment and maintained gains over time. We also investigated whether there were any differences in
change over time of overall EMS between patients who were recovered versus patients who were not recovered at
extended follow-up.
Methods: Young Schema Questionnaire –Short Form (YSQ-SF), Yale-Brown Obsessive-Compulsive Scale (Y-BOCS),
Beck Depression Inventory (BDI) were measured in 40 OCD patients in a general outpatient clinic before and after
group ERP, after 12-months and at extended follow-up. To analyze the predictors, a multiple regression analyses
was conducted. Changes in overall EMS was analyzed by mixed models procedures.
Results: The major finding is that patients with high pre-treatment YSQ-SF total scores were less likely to respond
to initial treatment or were more likely to relapse between post-treatment and the extended follow-up. The YSQ-SF
total score at pre-treatment explained 10.5% of the variance of extended long-term follow-up outcome. The entire
sample experienced a significant reduction in overall EMS over time with largest reduction from pre- to post-test.
There were no statistically significant differences in total EMS change trajectories between the patients who were
recovered at the extended follow-up compared to those who were not.
Conclusion: The results from the present study suggest that patients with higher pre-treatment EMSs score are less
likely to recover in the long-term after receiving group ERP for OCD. A combined treatment that also targets early
maladaptive schemas may be a more effective approach for OCD patients with elevated EMS who don’t respond to
standard ERP.
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Background
Obsessive-compulsive disorder (OCD) is a common dis-
order [1] that typically involves distressing, repetitive
thoughts that are often accompanied by compulsive be-
haviors [2].
Cognitive behavioral therapy (CBT) that includes ex-
posure and response prevention (ERP) is the psycho-
logical treatment of choice for OCD [3]. Although 60–
70% of patients improve with CBT [4], only approxi-
mately 25% of patients meet criteria for full recovery
post-treatment [5], and relapse rates range broadly from
0 to 50% [6]. Given that many patients do not recover
with CBT, it is crucial to investigate the characteristics
of patients who respond compared to those who do not.
Increased knowledge about predictors of CBT response
could reveal opportunities to modify treatment to im-
prove outcomes.
Previous research identifying predictors of treatment
outcome for OCD is mainly derived from patients given
individual CBT. Additionally, most studies examining
predictors of CBT outcomes are based on pre- to post-
treatment change or predictors of change after a short-
term follow-up period [7, 8]. Overall, reviews of the
short-term outcome literature on CBT for OCD reveal
inconsistent data on a range of predictors, but high
levels of pre-treatment OCD severity and co-occurring
depression are generally found to negatively influence
short-term CBT outcomes [7, 8]. Predictor studies of
longer-term outcomes (e.g., 5 or more years post-
treatment) of CBT, pharmacotherapy or a combination
for OCD are rare, and significant predictors vary from
study to study [9–15].
Of particular relevance to the current report, co-
occurring personality disorders (PD) have been identified
as negative predictors of CBT outcomes for OCD. In
shorter-term studies of CBT for OCD, comorbidity with
Cluster A, schizotypal PD, narcissistic PD and having
two or more PD’s have been associated with poorer out-
comes [16]. One longer-term study found that comor-
bidity with obsessive-compulsive PD was also associated
with poorer CBT outcomes [9]. Finally, pre-treatment
schizotypal features [17] and higher neuroticism scores
[11] have been linked to lower remission rates 5 to 6
years after initial treatment. These findings notwith-
standing, it is important to note that not all studies have
found that PDs have a negative impact on CBT out-
comes [18].
Given the likely negative impact of at least some types
of personality pathology on OCD treatment outcomes
and inconsistencies in the literature related to the influ-
ence of personality pathology on CBT for OCD, it is im-
portant to further investigate the impact of personality-
related variables on CBT response. One promising area
of investigation relates to the impact of early
maladaptive schemas (EMSs) on OCD symptoms and
treatment outcomes. Young [19, 20] has proposed that
personality pathology and recurrent symptom disorders
can be in part explained by the concept of EMS. EMSs
are defined as “a broad, pervasive theme or pattern com-
prised of memories, emotions, cognitions, and bodily
sensations regarding oneself and one’s relationships with
others developed during childhood or adolescence elabo-
rated throughout one’s lifetime and dysfunctional to a
significant degree” ([19], p., 7). EMSs are thought to de-
velop through a combination of biological factors and
unmet needs and experiences in the early years up to
adolescence. Young has identified 15 different EMSs that
are clustered in 5 categories called schema domains [21]
(see Table 1).
The identification of EMS has contributed to the de-
velopment of improved treatment models for patients
with severe PDs (e.g., borderline PD) [19, 22]. Schema
therapy (ST) [19, 20] was developed for patients with
personality disorders and chronic psychiatric conditions
who did not respond to traditional CBT. ST is an inte-
grative therapy combining a variety of treatment models
and theoretical approaches like cognitive behavioral
therapy, psychodynamic therapy, attachment theory and
developmental psychology. The main goal of ST is to
modify the EMSs and coping strategies that maintain the
schemas.
More recently, the impact of EMSs on a range of men-
tal disorders, including OCD, has been investigated [23,
24]. Descriptive studies show that OCD patients have el-
evated EMSs compared both to healthy controls [25–27]
and to patients with a range of other mental disorders
[28, 29]. Only three studies have explored the impact of
EMSs on pre- to post-treatment outcome for patients
with OCD [30–32]. In the first study, Haaland et al. [30]
identified Abandonment/Instability as a negative pre-
treatment predictor of outcome, using a combined sam-
ple of patients given either group or individual CBT.
Conversely, they found that high pre-treatment levels of
Self-sacrifice predicted a positive outcome. Finally, they
found that reductions in the Failure EMS during treat-
ment predicted better post-treatment outcomes. In a
second study on EMS and OCD treatment outcomes,
Thiel et al. [31] reported that Failure and Emotional in-
hibition were negative predictors of CBT response. Fi-
nally, a third study involving OCD patients receiving
individual cognitive therapy without ERP, found that the
Dependency/incompetence EMS significantly mediated
reductions in OCD symptoms over time [32]. Although
these previous reports are valuable, there is still incon-
sistency regarding specific pre-treatment EMSs or
schema domains that are significant associated with
OCD treatment outcomes. The reasons for these incon-
sistencies might be explained by small sample sizes,
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differences in patient samples (e.g., inpatients, outpa-
tients), variations in CBT treatments (e.g., CBT with or
without ERP, individual CBT, group CBT) and/or overall
length of treatment. Still, the EMS Failure seems to
function as both a pre-treatment predictor and moder-
ator of change over time, explaining between 18 and
21% of change with CBT for OCD [30, 31].
Personality-related factors, including EMSs, are gener-
ally thought to be relatively stable throughout the life-
course [19, 33] and thus may be particularly likely to
have an impact on OCD outcomes over time. However,
no study has to our knowledge examined the impact of
EMSs on OCD treatment-outcome beyond the post-
treatment assessment point. So far, we know little about
whether OCD patients who relapse or do not recover in
the long-term have higher EMSs at pre-treatment. Un-
derstanding the potential impact of pre-treatment EMSs
on long-term CBT outcomes could inform treatment
modifications for OCD patients with elevated pre-
treatment EMSs.
Building on this background, in the current study, we
examined the impact of baseline EMSs on group ERP for
OCD patients who were followed up several years after
completing treatment. The present study addresses three
research questions: 1) Do overall pre-treatment ratings of
EMS predict OCD symptoms many years later? 2) Is there
a difference in pre-treatment overall EMS ratings between
patients who achieved status as recovered versus those
who did not recover at different assessment points? and 3)
Is there any difference in overall EMS changes over time
between patients who recovered versus patients who still
had clinically significant OCD symptoms at long-term
follow-up? Beyond these specific research questions, we
also investigated the impact of pre-treatment ratings of
specific EMSs on change in OCD symptom severity in the
long-term as an exploratory aim.
Our central hypothesis in this paper is that patients with
no response to treatment or patients who relapsed during
the follow-up period would be more likely to have elevated
pre-treatment EMSs compared to those who responded to
initial treatment and maintained gains over time.
Method
Participants and procedure
A total of 65 patients were invited to participate in this
observational long-term follow-up study. All potential
Table 1 The 15 EMSs and the 5 schema domains of the YSQ-SF
Schema domains and early maladaptive
schemas (EMSs)
Description
Disconnection and Rejection Trouble obtaining stable and safe attachment to significant others. Persons with high scores in this domain may have experienced
a traumatic childhood that, in adulthood, causes repeated unstable relationships or avoidance of close relationships.
Emotional Deprivation The belief that others will not give emotional support
Abandonment/Instability The belief that important others will leave
Mistrust/Abuse The belief that one will be exploited by others
Social Isolation/Alienation The assumption of not belonging to others
Defectivness/Shame The belief of being worthless to others
Impaired Autonomy and Performance Difficulty functioning independently of others at same age. Persons with high scores in this domain may have experienced over-
involvement from their parents in childhood and, in adulthood, may have difficulty mastering requirements and goals.
Failure The belief that one is incompetent compared to others
Dependence/Incompetence The assumption that one can’t take care of oneself
Vulnerability to harm and illness Expectation that an accident or illness is imminent
Enmeshment/Undeveloped Self The feeling of fusion identity with important others
Other-Directedness Tend to emphasize other’s needs and feelings at the expense of their own. Persons with high scores in this domain may not have
experienced unconditional acceptance in childhood and in adulthood, they may be more likely to set aside their needs in favor of
others’ needs.
Subjugation The feeling that other’s needs are more important
Self-Sacrifice Attention to other needs at the expense of oneself
Overvigilance and Inhibition Strict control over own feelings and unrealistic high demands on oneself. In childhood, persons with a high score on this domain
may have learned to pay more attention to danger compared to pursuing happiness, thus increasing levels of pessimism and
worry in adulthood.
Emotional Inhibition The assumption that one must not show emotions
Unrelented Standards/Hypercriticalness The belief that one should do everything perfect
Impaired Limits Difficulty in respecting the feelings and needs of others. Persons with high scores in this domain may have experienced limited rules
and responsibilities in childhood, and as adults, may have difficulty with impulse control.
Entitlement/Grandiosity The belief of being superior to others
Insufficient self-control/Self-Discipline Lack of self-control and low frustration tolerance
The Table 1 is derived from Young [19]
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participants were treatment-seeking before they com-
pleted a manualized group ERP program for OCD [34]
in a general outpatient clinic 5 to 11 years prior to par-
ticipating in this study. The therapy was conducted in
groups of six patients with two therapists. The groups
met weekly for 12 weeks with each session lasting 2.5 h.
All participants had a primary diagnosis of OCD before
starting treatment. This original sample has been de-
scribed in two previously published reports [35, 36].
Forty (n = 40) of the 65 eligible patients agreed to par-
ticipate in the current long-term follow-up study. The
remaining 25 patients either refused to participate (n =
24) or were not traceable (n = 1). The Regional Commit-
tee for Medical and Health Research Ethics1 approved
this study. All participants gave written informed con-
sent before taking part in the current long-term out-
come study. All participants in the current study were
previously assessed at pre-treatment, post-treatment and
12-months following the original group ERP program.
For the present study, participants were assessed at
mean of 8.23 years (SD = 1.86) after completing treat-
ment (from now on referred to as “extended follow-up”).
Twenty-four (61.5%) of these participants reported that
they had received additional OCD treatment (i.e., add-
itional ERP; therapy not involving ERP; anti-obsessional
medication) between completion of group ERP and the
extended follow-up assessment. The mean age of the
participants at the extended follow-up was 43.6 years
and 77.5% were female. The mean Y-BOCS total score
at pre-treatment was 23.15 (SD = 3.63), indicating mod-
erate- to severe OCD symptoms. More information
about participant characteristics (marital- and
employment-status) and additional study procedures are
described elsewhere [36].
Measures
The Yale-Brown Obsessive Compulsive Scale (Y-
BOCS: [37, 38]). Obsessive-compulsive symptoms were
assessed with the Y-BOCS. The Y-BOCS is a 10-item
interview that provides sub-scores for obsessions, com-
pulsions and a total score of OCD severity. The total
score ranges from 0 to 40, with higher scores indicating
greater OCD severity. The Y-BOCS has been docu-
mented as a reliable and valid tool [39].
Young Schema Questionnaire – Short Form (YSQ-
SF: [21]). The Young Schema Questionnaire (YSQ) is a
self-report inventory developed to assess underlying
EMSs [40]. In the current study we used the original
short version that contains 75 items and assess 15 spe-
cific early maladaptive schemas developed from the ori-
ginal long version of YSQ, which consist of 205 items
[40]. Similar psychometric properties, validity and levels
of clinical utility are reported between YSQ-SF and the
long version of YSQ [41]. EMSs are organized in five
schema domains in YSQ. The five schema domains are;
(1) Disconnection and Rejection (trouble getting stable
and safe attachment to significant others), (2) Impaired
Limits (difficulty in respecting the feelings and needs of
others), (3) Other-Directedness (tendency to emphasize
other’s needs and feelings on the expense of their own),
(4) Overvigilance and Inhibition (strict control over one’s
own feelings and unrealistic high demands on oneself)
and (5) Impaired Autonomy and Performance (difficulty
functioning independently of others at same age). Each
item is rated using a 6-point Likert scale from 1 = “com-
pletely untrue of me” to 6 = “describes me perfectly”.
There are five questions for each of the specific 15 EMSs
(see Table 1). The total sum (YSQ-SF total score) is the
addition of all raw item scores divided by 75. YSQ-SF is
widely used across cultures and translations (e.g.
Canada: [42], Belgium [43];, Spain [44], Britain [41],
Australia and South-Korea [45]) and has shown good to
excellent consistency both for the YSQ total score and
the individual EMSs in Norwegian samples [46, 47]. The
Norwegian version of YSQ-SF has been translated back
to English with no substantial differences in meaning
from the American version for the 75-item scale [46].
YSQ-scores have shown discriminant validity between
clinical populations in Norway [33, 46, 48] and between
clinical and non-clinical samples [33]. Test-retest reli-
ability of YSQ-SF in a Norwegian study has been shown
to be satisfactory, with a mean duration of 72 days [46].
Finally, in the current study, Cronbach’s alpha for YSQ-
SF total scores ranged from 0.97 to 0.99 at the four
measurement occasions, indicating excellent internal
consistency [49].
Beck Depression Inventory (BDI: [50]) is a self-report
inventory for depression symptoms, consisting of 21 items
rated on a four-point Likert scale, ranging from 0 (“not at
all”) to 3 (“severe”). The BDI has good psychometric prop-
erties [51]. In the current sample, Cronbach’s alpha for
BDI were excellent, ranging from 0.92 to 0.94.
Definition of recovery
To define the status as recovered, we used the same
classification [52] as in the original study by Haaland
et al. [35]. To be classified as recovered, participants
must have a post-treatment Y-BOCS total score of 14 or
less and must have improved at least 8 points from pre
to post-treatment. Sixteen (40%) patients achieved re-
covered status at the extended follow-up whereas 24 pa-
tients (60%) did not [36].
Sample size determination
We assumed that 50% of the invited participants (N =
65) would be classified as recovered at the extended1REC number; 2013/ 1210 Sør-Øst
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follow-up based on data from the previously published
12-month follow-up study by Haaland et al. [35]. More-
over, we expected that most patients would be willing to
participate in the extended follow-up, which would likely
yield a sample of 25 participants in both the recovered
and the non-recovered groups. Statistical power analysis
performed with regard to the detection of differences be-
tween the groups on the potential predictor variables
showed that with an α-level at 0.05 and a β-level at 0.20,
50 participants would be sufficient to detect differences
of a moderate effect size (Cohens d = 0.80) with a two
tailed t-test.
With respect to YSQ-SF total score, the legitimacy of
these analyses was supported by data from Thiel et al.
[31] who found a difference of .3 between responders
and non-responders and a pooled SD of .75 at post-
treatment. At the extended follow-up in our study, it is
to be expected that the difference between recovered
and non-recovered patients would be considerably lar-
ger, but we used a conservative estimate of .60 in the
analyses. Using these numbers in a power calculation
gave an effect size of .80 and a power of .80 as well.
With a reduction from 50 to 40 participants, power di-
minished from .80 to .70, which we considered to be ad-
equate to perform the predictor analyses since the
difference of .60 is a very conservative estimate.
Data analyses
The patterns of missing values for YSQ-SF protocols
were examined. Independent t-tests were used to com-
pare pre-treatment measures between patients who were
recovered versus those who did not recover at the vari-
ous measurement points. In addition, independent t-
tests were used to compare the pre-treatment YSQ-SF
total score of those who relapsed or had a delayed remis-
sion with those who were either unchanged or met cri-
teria as recovered across all four measurement points
(pre- and post-treatment, 12-month and the extended-
follow-up). Fisher’s exact tests and independent sample
t-tests were used to investigate differences in demo-
graphic variables between participants who were recov-
ered and participants who were not recovered at the
extended follow-up. All tests of differences were per-
formed as two-tailed, unless otherwise noted.
Multiple regression analysis was conducted for pre-
dicting outcome with the Y-BOCS at extended follow-up
as the independent variable. In the regression analysis
we explored whether pre-treatment YSQ-SF total score
was related to the extended follow-up outcome mea-
sured by Y-BOCS. Residual plots and histograms for re-
siduals were checked which showed normal distribution
of the residuals.
The third research question was addressed by the
mixed models procedures in SPSS. YSQ-SF total score
was entered as the outcome (dependent) variable.
“Time” and “group” were entered as covariates, as well
as the interaction between “time” and “group”. Time was
coded as 0, 1, 2, and 3, corresponding to the four meas-
urement occasions (pre-treatment, post-treatment, 12-
month follow-up and 8-year follow-up). “Group” is a
dummy variable indicating patients who were recovered
versus patients who were not recovered from their OCD.
Log likelihood estimation (LLH) and Akaike Information
Criterion (AIC) were used to evaluate model fit.
The first step in the modelling procedures was to
model the mean structure of the data [53], in which only
“time” was included (LLH = 342, AIC = 354). The second
step was to include a random intercept, which implies
that each patient was assigned an individual estimate of
the YSQ-SF total score at pre-treatment. This step also
included the modelling of the covariance structure of re-
siduals, comparing a diagonal covariance matrix with an
autoregressive covariance matrix. The second step re-
sulted in a considerably better model fit (LLH = 201,
AIC = 211). In the third step, we compared a pure linear
model (a straight regression line through all measure-
ment occasions) with a linear spline model with the knot
at post-treatment. This model implies that change
trajectories were analyzed for two different time periods
within the same model, i.e., from pre-treatment to post-
treatment (where the knot was positioned) and from
post-treatment to extended follow-up (through 12-month
follow-up). The model fit did not change as compared
with the second model (LLH = 200, AIC = 212). The
fourth and last step was to include the interaction with
“time” and “group” in the simple linear model as well as in
the linear spline model to examine whether recovered pa-
tients had different change rates than non-recovered pa-
tients with respect to EMS. The inclusion of the “time by
group” interaction in the simple linear model yielded a
slight improvement of model fit (LLH = 192, AIC = 206).
However, the linear spline model did not improve by in-
cluding this interaction (LLH= 191, AIC = 209).
Effect sizes for the YSQ-SF total scores were calculated
utilizing a formula derived from Cohen [54].2 To reduce
the risk of Type I errors due to multiple comparisons, a
Benjamini-Hochberg procedure with false discovery rate
was set at 10% for all analysis [55]. These methods are in
line with the recommendation of the American Statis-
tical Association (ASA) [56]. The Benjamini-Hocberg
procedure was preferred above the Bonferroni correction
because of risk for type II errors with the small sample
sizes [57] in the present study. P-value in the current
study was 0.045 corresponding to a p-value of 0.05 for a
single comparison. All statistics were calculated using
2Cohen’s d = M1M2SDpooled
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IBM SPSS version 23.0 [58] except Benjamini-Hocberg
procedure [55] that was performed by hand.
Collinearity statistics
Multicollinearity among predictor variables was statisti-
cally investigated by computing variance inflation factors
(VIF). The highest VIF was 1.67 which is far below the
suggested cut-off value of 10 that indicates a collinearity
problem [59]. As a further part of the multicollinearity
examination, correlation coefficients were conducted
among predictor variables. A linear regression analyses
assume that the degree of correlation should not exceed
0.90 due to problems with multicollinearity [60]. As
shown in Table 2, a significant moderate degree of cor-
relation was observed between the dependent variable
and the pre-treatment YSQ-SF total score. A moderate
to high degree of correlation was found between the
YSQ-SF total score and the two other independent vari-
ables, BDI and Y-BOCS, indicating that problems with
multicollinearity are not a serious problem in the
current study.
Missing data
Sixteen YSQ-SF protocols were totally missing and 3
more protocols were excluded due to missing items.
Taken together; 3, 5, 6 and 5 of the YSQ-protocols were
missing at respectively pre-test, post-test, 12-month and
the extended follow-up. Little’s MCAR test was run on
the remaining data, and it indicated that data was not
missing completely at random (MCAR). However, when
the pattern of missing variables was closely examined,
using the method described by Little and Rubin [61], it
was not possible to find any definitive pattern. There-
fore, we proceeded with analysis treating the data as
missing at random (MAR). Of the remaining YSQ-SF
protocols, 0.3% of the items were missing for the four
measurement points. One participant had 19 of 75 items
that were missing due to data management issues. This
participant was excluded, and missing data for YSQ-SF
was by this reduced to 0.2%. To reduce missing data for
the YSQ-SF total score, mean imputation was applied to
individual scale items when fewer than 5% of items were
unanswered [62]. Single EMSs were excluded if any
items were missing.
Results
Comparison of additional treatment between the
recovered versus the not recovered group in the follow-
up period
Ten participants (62.5%) in the recovered group and 14
participants (58.33%) in the non-recovered group re-
ported that they had received additional treatment be-
tween the initial group ERP and the extended follow-up.
There were no significant differences between the recov-
ered group and non-recovered group regarding whether
they received additional treatment of any kind or
whether they received a specific type of treatment. The
largest difference between the groups was that nine of
the 24 (37.5%) participants in the non-recovered group
and two (12.5%) of the participants in the recovered
group received additional ERP for OCD in the time
period between the end of the original group CBT and
the long term follow-up assessment point [M = 0.41
(0.50) vs. M = 0.14 (.36); t (34) = 1.84, p = .075].
Comparison of demographics between the recovered
versus the not recovered group at the extended follow-
up
There were no significant differences with respect to
gender (p = 1.00), age [M = 43.56 (11.62) vs. M = 40.91
(13.52); t (37) = .637, p = .528], marital status (married
and cohabiting versus single, divorced and separated)
(p = .728) and employment status (employed, student,
retired versus unemployed, homemaker and disabled)
(p = .514) between the recovered and the non-recovered
group.
YSQ-SF total score for follow-up participants versus non-
participants
To control for selection bias, the YSQ-SF total scores
were compared between the group (n = 40) that agreed
to participate in this long-term follow-up study and
those who were contacted but refused to participate
(n = 25). There were no significant differences at pre-
treatment [M = 2.36 (0.84) vs. M = 2.41 (0.67); t(58) =
0.228, p = .821], post-treatment [M = 2.18 (0.82) vs. M =
2.10 (0.72); t(52) = 0.075, p = .941] and change scores at
post-treatment [M = 0.19 (0.45) vs. M = 0.21 (0.49);
t(49) = 0.122, p = .903] between these groups.
Research question 1: predictive value of the pre-
treatment YSQ-SF total score and OCD symptom severity
at the extended follow-up
We investigated the factors that most influenced the OCD
symptom severity at the extended follow-up. The
dependent variable was the total Y-BOCS score at the ex-
tended follow-up time point. Due to the limited sample
size (N = 40), only 3 independent factors measured at pre-
treatment were included in the multiple regression
Table 2 Correlations between pre-treatment Y-BOCS, BDI and
YSQ-SF total score and Y-BOCS at the extended follow-up
1 2 3 4
1 Y-BOCS extended FUa
2 Y-BOCS pre-test .30
3 BDI pre-test .16 .27
5 YSQ-total pre-test .36* .50** .51**
FUa Follow-up. *Correlation is significant at p < 0.05. **Correlation is significant
at p < 0.01
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analysis: 1) OCD symptom severity (Y-BOCS), 2) Depres-
sion symptoms (BDI), and 3) Maladaptive schema total
score (YSQ-SF). In the first step, the three independent
variables were entered one by one in a single linear regres-
sion analysis. Only the YSQ-SF total score was signifi-
cantly related to the dependent variable (p = 0.029,
adjusted R square = .105). To investigate whether the three
independent variables adjusted for each other, thus giving
better predictive ability, they were entered together in a
backward elimination multiple-regression analysis (see
Table 3). This analysis showed no change from the simple
regression analysis. YSQ-SF total score at pre-treatment
explained 10.5% of the obsessive-compulsive symptoms at
the extended follow-up.
According to the best estimate of the regression line
for Y-BOCS at the extended follow-up, an unstandard-
ized B of 3.065 indicates that on average, an increase of
1 unit in YSQ-SF total score is associated with approxi-
mately a 3 unit increase in Y-BOCS at the extended
follow-up.
Research question 2: differences in pre-treatment YSQ-SF
total score between those who recovered and those who
not recovered at post-test, 12-month and the extended-
follow-up, respectively
Independent sample t-tests showed that the non-
recovered group at the extended follow-up had signifi-
cant higher pre-treatment YSQ-SF total score, as well as
BDI scores, compared to the recovery group (Table 4).
These differences were not significant between patients
who were recovered versus not recovered at post-test
and 12-month follow-up, respectively. There were no
significant differences in pre-treatment OCD severity be-
tween the recovered and not-recovered groups neither
at post-treatment, 12-month nor the extended follow-up
time points.
A closer analysis showed that 19 (47.5%) of the partici-
pants had changed their status between recovered and
non-recovered from post-test to the extended follow-up.
Eleven participants (27.5%) had relapsed between post-test
and the extended follow-up and had significantly higher
YSQ-SF total score at pre-treatment compared to those
who were recovered at the extended follow-up [M = 2.77
(0.85) vs. M = 1.91 (0.52); t(24) = 2.98, p = .009, Cohen’s
d = 1.19]. In addition, eight participants who had remis-
sion later than post-test had a significant lower YSQ-SF
total score at pre-treatment compared to those that were
non- recovered [M = 2.05 (0.57) vs. M = 2.69 (0.89);
t(27) = 2.21, p = .042, Cohen’s d = 0.86].
Research question 3: change in YSQ-SF total scores from
pre-treatment to through all measurement points
Figure 1 displays the YSQ-SF total score change profiles
for recovered and non-recovered patients. It can be seen
that the decrease in YSQ-SF total scores was most pro-
nounced from pre-treatment to post-treatment for both
groups. Moreover, the non-recovered group had higher
YSQ-SF total scores at pre-treatment. This difference
remained stable over time.
Indeed, the results of linear mixed models analyses indi-
cated that there was a slight but significant decrease in
YSQ-SF total score from pre-treatment to extended
follow-up for the entire sample (decrease of .14 points per
measurement occasion, t = 4.6, p = .000). Furthermore, the
change in YSQ-SF total score was greater from pre- to
post-treatment than from post-treatment to the extended
follow-up period for the entire sample. A linear spline
model with a knot at post-treatment showed that the de-
crease from pre-treatment to post-treatment was larger
(.22 points, t = 3.0, p = .003) than the decrease from post-
treatment through 12-months follow-up to extended
follow-up (.11 points per interval, t = 2.5, p = .017).
The linear model including the “time” by “group”
interaction showed that the non-recovered group had
higher YSQ-SF total scores at pre-treatment than the re-
covered group (t = 2.9, p = .005). However, EMS scores
decreased at the same rate in both groups (t = .635,
p = .529). The most complex model, the one in which
the “time” by “group” interaction was included for two
different time periods, showed similar results finding no
difference in YSQ-SF total score change rates across the
two groups, not from pre-treatment to post-treatment,
neither from post-treatment to extended follow-up.
Outlier analyses
Inspection of the residuals plot showed that one patient
in the non-recovered group had very high YSQ-SF total
scores at the follow-up investigations (see Fig. 1). Mixed
models analyses without this patient did not change the
overall results. In the simple linear model, the change rate
Table 3 Multiple backward elimination regression analysis using
Y-BOCS at the extended follow-up as dependent variable
Factors Beta T P R2
Model 1 0.052
Y-BOCS pre 0.046 0.246 0.807
BDI pre 0.022 0.115 0.909
YSQ-SF total pre 0.326 1.552 0.130
Model 2 0.080
Y-BOCS pre 0.047 0.253 0.802
YSQ-SF total pre 0.336 1.818 0.078
Model 3 0.105
YSQ-SF total pre 0.360 2.828 0.029*
*Correlation is significant at p < 0.05, Y-BOCS pre Yale-Brown Obsessive-
Compulsive Scale, pre-treatment scores, BDI pre Beck Depression Inventory,
pre-treatment scores, YSQ-SF total pre The Young Schema Questionnaire -
Short Form, total pre-treatment scores
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became somewhat larger (.16 points per occasion, t = 5.7,
p = .000), and in the interaction model, the time x group
interaction remained insignificant (t = 1.2, p = .219).
Effect sizes for change in YSQ-SF total score
We followed Cohen’s [54] proposal to classify effect sizes
as small (0.20–0.49), medium (0.50–0.79) or large (0.80
and above) in improvement in the YSQ-total score. For
the entire sample the effect size (Cohens d) was small
from pre- to post-test (d = 0.30), and remained small
through the 12-month follow-up (d = 0.41) and to the ex-
tended follow-up (d = 0.48). Both the non-recovered (d =
0.37) and recovered group (d = 0.34) also had a small ef-
fect size for pre- to post-test. However, for the recovered
group the effect size was medium (d = 0.57) at 12-month
follow-up and large (d = 0.83) at the extended follow-up.
For the non-recovered group, the effect size was still small
(d = 0.39) at 12-month follow-up and medium (d = 0.50)
at the extended follow-up.
The impact of specific pre-treatment EMSs on long-term
OCD symptom severity as an exploratory aim
To obtain more detailed information of the relationship
between specific pre-treatment EMSs and extended
Table 4 Comparing pre-treatment scores between the recovered and non-recovered patients at post-treatment, 12-month- and the
extended follow-up




t Sig. 2 tailed
Post-treatment YSQ-SF total score 13 2.09 (0.79) 24a 2.53(0.86) 1.52 ns.
BDI 13 15.15 (8.06) 27 16.95 (12.08) 0.56 ns.
Y-BOCS 13 23.69 (2.90) 27 22.89 (3.96) −0.73 ns.
12-month F.U.d YSQ-SF total score 13a 2.14 (0.68) 18 2.59 (0.85) 1.59 ns.
BDI 16 16.17 (9.80) 18 17.31 (13.05) 0.29 ns.
Y-BOCS 16 22.78 (2.29) 18 22.63 (4.32) −0.13 ns.
Extended F.U.d YSQ-SF total score 15b 1.91 (0.52) 22c 2.69 (0.90) 3.33 0.02*
BDI 16 12.31 (8.53) 24 19.08 (11.53) 2.13 0.04*
Y-BOCS 16 22.50 (2.78) 24 23.58 (4.10) 0.97 ns.
a = 3 YSQ-SF protocols missing, b = 1 YSQ-SF protocols missing and c = 2 YSQ-SF protocols missing, d = Follow-up, * = Correlation is significant at p < 0.05 and ns
not significant
Fig. 1 Clinical course of YSQ-SF total score for recovered versus non-recovered patients at the extended follow-up
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follow-up outcomes, independent sample t-tests were
conducted for the 15 EMSs. Table 5 shows that 10 of
the 15 schemas (Abandonment/Instability, Emotional
Deprivation, Mistrust/Abuse, Social Isolation/Alienation,
Defectiveness/Shame, Dependence/Incompetence, Vul-
nerability to Harm and Illness, Subjugation, Emotional
inhibition and Entitlement/Grandiosity) at pre-treatment
were significant lower in the recovered group at the ex-
tended follow-up comparing to those who were not re-
covered. Five of these 10 schemas belong to the domain
Disconnection and Rejection while the remaining five
EMSs were evenly distributed on the other four do-
mains. In addition, there were also a trend toward lower
values on the remaining five EMSs, but these were not
significantly different between the groups.
Discussion
This study sought to expand the current knowledge of
the relationship between early maladaptive schemas and
OCD symptom severity using a longitudinal design. The
key findings in this study are: 1) Pre-treatment YSQ-SF
total score was significantly associated with more severe
OCD symptoms at the extended follow-up compared to
pre-treatment depression and obsessive compulsive
symptom severity; 2) Non-recovered patients at ex-
tended follow-up had significantly higher scores on early
maladaptive schemas (i.e. YSQ-SF total score) at pre-
treatment compared to the recovered patients; and 3)
Linear mixed model analysis showed that the largest re-
duction of YSQ-SF total score occurred from pre-
treatment to post-treatment with smaller but still signifi-
cant reductions from post-treatment to the extended
follow-up both in the recovered- and the non-recovered
groups.
As far as we know, this study is the first to show that
pre-treatment early maladaptive schemas may be associ-
ated with OCD symptom severity many years after treat-
ment. Earlier studies examining the role of early
maladaptive schemas for OCD have had a pre- to post
design and detected specific EMSs to be negative (e.g.
Abandonment/Instability and Failure) or positive (Self-
sacrifice) predictors of treatment outcome [30, 31].
Our analysis of individual EMS scores must be seen as
exploratory given our limited sample size. This limitation
notwithstanding, it is important to note that t-tests indi-
cated that 10 of 15 pre-treatment YSQ-SF sub-scores were
significantly higher in the non-recovered group compared
to the recovered group. These findings suggest that a
number of specific maladaptive schemas may negatively
impact long-term outcomes after group ERP. Of particular
interest is the fact that all five EMSs belonging to the Dis-
connection and Rejection domain (Abandonment/
Table 5 Comparing the 15 pre-treatment EMSs between recovered and non-recovered patients at the extended follow-up




t Sig. 2 tailed
Disconnection and Rejection
Abandonment/Instability 1.76 (0.81) 2.62 (1.27) 2.53 .016*
Emotional Deprivation 1.29 (0.41) 2.20 (1.10) 3.51 .002**
Mistrust/Abuse 1.27 (0.28) 1.73 (0.84) 2.41 .023*
Social Isolation/Alienation 1.37 (0.48) 2.08 (1.28) 2.26 .025*
Defectiveness/Shame 1.32 (0.44) 2.15 (1.36) 2.67 .013*
Impaired Autonomy and Performance
Failure 1.45 (0.51) 1.97 (1.16) 1.88 .070
Dependence/Incompetence 1.45 (0.51) 1.87 (0.88) 2.15 .039*
Vulnerability to Harm and Illness 1.32 (0.50) 2.05 (1.03) 2.86 .007*
Enmeshment/Undeveloped Self 1.51 (0.68) 2.05 (1.03) 1.80 .080
Other-Directedness
Subjugation 1.38 (0.61) 2.08 (1.35) 2.13 .041*
Self-Sacrifice 2.21 (0.51) 2.82 (1.27) 1.99 .056
Overvigilance and Inhibition
Emotional Inhibition 2.12 (0.51) 2.66 (0.88) 2.63 .024*
Unrelenting standards/Hypercriticalness 2.39 (1.08) 3.14 (1.30) 1.97 .058
Impaired Limits
Entitlement/Grandiosity 1.50 (0.48) 2.03 (1.17) 2.69 .012*
Insufficient Self-Control/Self-Discipline 1.42 (0.49) 1.70 (0.63) 1.52 .138
t = independent t-test, *significant at p < 0.05, ** significant at p < 0.01
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Instability/Instability, Emotional Deprivation, Mistrust/
Abuse, Social Isolation/Alienation and Defectiveness/
Shame) were significantly higher at pre-treatment in the
non-recovered patients at the extended follow-up com-
pared to recovery group. Support for this finding is also
found in the study by Thiel et al. [31] who reported that
three out of four baseline EMSs (Mistrust/Abuse, Social
Isolation/Alienation and Defectiveness/Shame) were sig-
nificantly higher in the group of patients categorized as
non-responders after CBT with ERP for OCD. Indirect
support is also found in a comparative study that found
OCD patients, compared to normal controls, had signifi-
cantly higher scores on two of three EMSs (Defectiveness/
Shame and Social Isolation/Alienation) [26] after control-
ling for depression. According to Young [19], patients
with elevated schemas in the domain Disconnection and
Rejection have little ability to relate safely and satisfactorily
to others and are often the most damaged (i.e., the most
severe personal pathology). Schemas from this domain are
also more prevalent among patients with borderline per-
sonality disorder [63]. Future long-term studies with larger
samples are needed to definitively investigate the impact
of specific EMSs on CBT for OCD.
Our finding that higher baseline EMSs was negatively
associated with OCD symptom severity at extended
follow-up is consistent with studies indicating that pre-
treatment PDs are also related to poorer outcomes after
CBT for OCD [9, 17]. Conversely, our findings that
higher pre-treatment OCD and depression symptoms
was not associated with OCD symptom severity at ex-
tended follow-up is in contrast to studies that have
found them to be predictive of poorer CBT outcomes
over the long-term [11, 12].
Although there are no other studies that have exam-
ined relationship between pre-treatment EMSs on very
long-term treatment outcomes for OCD or for other
anxiety disorders, there is one comparable long-term
study for depression severity and episodes of Major De-
pression. In this study, two of five baseline schema do-
mains, Undesirability (domain from the long version of
YSQ) and Impaired Limits, predicted depression severity
and number of major depressive episodes after 9 years,
respectively [64]. Our results add to this limited litera-
ture suggesting that elevated pre-treatment EMSs may
be an important negative indicator of the long-term
course for a range of mental disorders.
It is interesting to note that although significant differ-
ences in pre-treatment YSQ-SF total score between par-
ticipants who were recovered versus those not recovered
were observed at extended follow-up, there were no sig-
nificant differences in YSQ-SF scores between these
groups at post-treatment or at 12-month follow-up.
These results are indirectly supported by another long-
term follow-up study finding that the presence of at least
one comorbid PD did not predict outcomes for OCD pa-
tients in the short-term but were significant negative
predictors 5 years after treatment [11]. A possible ex-
planation for these results is that patients with high de-
gree of personality pathology (i.e., high score on YSQ)
may experience short-term reductions in their OCD
symptoms after CBT but may struggle to maintain the
improvement over time, due, at least in part, to their
personality symptoms. This explanation is supported in
the current study where we found that several of the pa-
tients who first benefited from treatment and later re-
lapsed at the extended follow-up had higher pre-
treatment EMSs. In addition, those patients who did not
improve from pre- to post-treatment but were rated as
recovered at any follow-up period, had significantly
lower EMS scores at pre-treatment compared to those
who never recovered. Rebound in OCD symptoms after
successful ERP or comprehensive cognitive therapy
among patients with certain concurrent personality traits
or PDs has also been reported in other studies [65–67].
A related point of interest is our finding that YSQ-SF
total score showed modest but significant decreases for
the entire sample over time after a relatively brief group
ERP. The most pronounced decrease in EMS for all par-
ticipants was observed just after the active treatment but
small significant reductions in YSQ-SF total score at 12-
month and extended follow-up were also observed in both
the recovered and non-recovered groups. It is important
to note, however, that although significant, the effect sizes
of these changes were small. Other studies have also found
similar small, but significant changes in single EMSs from
pre- to post- OCD treatment with ERP [30, 31] or cogni-
tive therapy [32]. Modest decreases in EMSs have also
been observed following brief CBT for social anxiety [68]
and for other anxiety and depressive disorders [69]. Inter-
estingly, the changes in YSQ-SF total score did not closely
follow changes in OCD symptoms over time. Both the re-
covered and non-recovered groups had similar modest
improvements in EMSs over time even though the recov-
ered group experienced substantially greater decreases in
OCD symptoms. In short, OCD improvement did not
seem to have a proportional positive impact on maladap-
tive schema. Very small changes in EMSs over time for all
participants and the lack of substantial changes in EMSs
even for those who achieved large gains in OCD may not
be surprising. According to Young [20] early maladaptive
schema are deeply entrenched as the result of develop-
mental processes and that they likely require intensive
schema-focused therapy in order to make substantial
changes in these beliefs.
The limitations and strengths with this study
This study has limitations. For example, there was no
control group, making it difficult to draw conclusions
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about treatment effects, especially since many partici-
pants had received additional treatment during the
follow-up period [36]. The study was not designed to
find causal relationships between reduction in EMSs and
OCD symptoms. In addition, patients were treated with
ERP which is not designed to change EMSs, but is spe-
cifically targeted toward improving OCD symptoms.
Further, other potentially clinically important variables
that have been shown previously to be significant predic-
tors of outcome for OCD treatment have not been ex-
amined. For example, because of limited statistical
power, hoarding pathology, increased anxiety, certain
OCD symptom subtypes, unemployment, and being sin-
gle/not married, were not included in the analysis, which
is relevant because they have all been shown, at least in
some studies, to be negative predictors for OCD treat-
ment outcome [8]. As mentioned above, a shortcoming
is also that the sample size did not allow for the system-
atic investigation of individual EMSs on outcomes over
time. Future long-term outcome studies with larger sam-
ples would be very useful in addressing these important
issues. Additionally, there is a substantial length of time
between the 12-month follow-up and the extended
follow-up periods. It would have been of interest to
know more about the relationship between EMSs and
OCD symptoms annually throughout the extended
follow-up period. Annual assessments are particularly
relevant for OCD given that waxing and waning of
symptoms over time is commonly observed [70]. Finally,
we did not assess for PDs in this study. Given that pa-
tients with personality psychopathology generally exhibit
high EMSs [48], it is desirable to assess and control for
PD comorbidity when studying relation between EMSs
and OCD symptoms.
These weaknesses notwithstanding, a key strength with
the current study is that we explore follow-up data for
EMS at a mean of 8 years after OCD treatment. No
other studies of CBT for OCD provide any follow-up
EMS data beyond the post-treatment data point. Fur-
thermore, contrary to some CBT studies for OCD [7, 71,
72], patients with severe PDs and/or major depression
were included in this community-based project. There-
fore, the participants in this study may be seen as more
representative of typical treatment-seeking patients in
routine outpatient clinics.
Conclusions
This is the first study to longitudinally examine early
maladaptive schemas’ impact on OCD symptom severity
over the long-term. The results from the present study
suggest that patients with higher pre-treatment EMS
scores are less likely to recover in the long-term after re-
ceiving a 12-week course of group ERP for OCD. Poorer
response to treatment among persons with high pre-
treatment EMS scores is also underscored by the fact
that many more of these patients sought additional
treatment in the follow-up period compared to those
with lower EMS scores.
A clinical implication may be that patients with high
pre-treatment EMSs scores may benefit from a tailored
treatment that targets both their OCD symptoms and
personality-related problems. Special attention should be
given to OCD patients with endorsed schemas in the do-
main Disconnection and Rejection. Particular focus on
building a working alliance may be needed in this group
of patients. Perhaps individual ERP may be a better ap-
proach than group ERP for these patients given that in-
dividual ERP allows for more time to develop a personal
relationship with the therapist. It is also possible that
persons with high Disconnection and Rejection EMSs
may benefit from schema therapy or other clinical ap-
proaches that emphasize alliance building, either prior to
or during exposure and response prevention. Promising
results using a combination of schema therapy and CBT
for non-responders, drop-outs or initial CBT refusers
have been reported in two OCD case examples [73] and
in an open trial of 10 OCD inpatients [74] suggesting
that it might be advantageous for OCD patients with
high pre-treatment EMSs as well.
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